Recent work has shown a mortality benefit in critically ill patients when hyperglycaemia is prevented. We performed a telephone survey of all ICUs in Scotland to identify methods of glucose control, their ability to achieve target ranges, and any related audit processes. In 23 of 26 adult ICUs blood glucose is controlled by formalised insulin protocols, mostly (19/26) similar to that described by Van Den Berghe. Few units are auditing the quality of this inexpensive and effective intervention.
Introduction
It has long been recognised that hyperglycaemia is associated with increased mortality in a variety of critical illnesses, e.g. acute myocardial infarction 1 , stroke 2 and trauma 3 . Recent evidence has shown a mortality benefit in general intensive care patients by using insulin protocols to gain and maintain tight normoglycaemia 4, 5 .
Aims
Our three primary aims were to establish: 1. The methods of controlling blood glucose in use in Scottish ICUs. 2. The blood glucose target ranges set by individual units. 3 . Whether target blood glucose levels are achieved and the audit processes used to measure this.
Methods

A telephone survey was conducted of all
Scottish hospitals with an adult ICU [n = 26 (25 general/mixed, 1 neuro)], enquiring about use of formal insulin protocols, other methods of controlling blood glucose, target ranges chosen and the use of audit processes to determine if these had been achieved. 
Results
Methods of control
ICU units Beds
Rigid Protocol 19 145
Individual approach 4 25
Sliding scale 3 16
Target Ranges
There is a considerable variation in the target range adopted by units. Of 23 units (91.4% beds) using a target range (rigid protocol or individualised system) the majority [19 units, 134 beds (78.8%)] set a lower limit of <5mmol.l -1 . Upper limits showed less consensus, with almost equal number of units choosing the four quartiles between 6 & 8mmol.l -1 .
Figure 2: Range limits
The target tolerance range (the difference between lower and upper limits) is also of interest, with 16 of the 23 units [133 beds (78.2%)] having set ranges aiming to restrict variation to <3mmol.l -1 and 4 [26 beds (15.3%)] setting an ambitious target range of <2mmol.l -1 .
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Discussion
General intensive care has seen some significant advances over the recent past, including the first large scale randomised controlled trials involving the sickest of patients. This research has led the adoption of interventions proven to reduce mortality and morbidity, e.g. ARDSnet protocol for ventilation in acute respiratory distress syndrome 6 , recombinant activated protein C for sepsis 7 , low dose corticosteroids for inotrope-dependent sepsis-related circulatory failure 8 , and maintenance of tight control of normoglycaemia with insulin 4 . Many of these have been integrated in the international 'Surviving Sepsis Campaign' 9 . The acceptance and implementation of this evidence by the majority (23/26, 91.4% of beds) of Scottish units is encouraging. The absence of published evidence on the benefits of a rigid protocol versus an individualised daily scale limits conclusions about the decision to favour differing methods of glucose control.
Target Ranges
The wide variety of ranges of glucose concentration reported to be beneficial to patients is reflected in Scottish critical care practice. There are significant variations in both the absolute limits set and the 'tightness' of the range, often arising as a result of alterations made during implementation of protocols. Although these variations restrict comparison of the degree of control, the fact that 4 units set tolerance ranges of less than 2mmol.l -1 between upper and lower limits suggests that very tight control of acceptable glucose levels is practicable. Resistance to using tight limits has centred on the possibility of overt hypoglycaemia, but with good implementation this would seem avoidable.
Audit
In the absence of reliable audit of the implementation of this intervention, and only a minority of units (5 out of 26) appearing to disseminate information on results, concern must exist about overall achievement of tight glycaemic control. Although medical students, trainees or nurses may have indeed been diligently collecting data and performing small scale surveys, without the dissemination of such information to the wider staff progress is inevitably limited. It is the responsibility of all units to audit how well they are achieving their target levels (no matter which range they are using), and to keep all involved workers informed about the results, so that they can attempt to constantly improve. Our survey suggested that only one unit re-audited levels of control on a month-to-month basis; their control levels were up to 80% of all glucose results being within their set range (a very tight range of only 1.7mmol.l -1 ). Only 5 of the 26 units had recollection of a survey/audit being completed within the previous12 months, with control levels ranging from 55% to 85%. This would seem to indicate scope for further improvements in achieving targets, and that very tight ranges can be applied in a general intensive care unit.
Conclusions
Most ICUs (23 of 26, 91.4% of beds) in Scotland use formalised approaches to maintaining normoglycaemia, with only 3 units (8.6% of beds) having no formal control mechanism. Discrepancies were identified in the definitions of normoglycaemia as well as the tolerance range (i.e. between 1.5 & 4mmol.l -1 ) accepted. Although there is scope for improving the audit of glycaemic control within Scottish ICUs, the practice of tight control has to be seen in the wider context of overall intensive care. 
